Pat Cotroneo has sold FGEN and made no open-market buys since May 2016
SVP, Finance, CFO at Fibrogen Inc
SEC CIK 0001621334 · Filings on SEC.gov ↗
Every filing
39 filings since May 2016, newest first
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
SVP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Fibrogen Inc
VP, Finance, CFO
Filings come from SEC EDGAR. Not investment advice.